Edward M. Messing, MD, FACS
Dr. Messing received his M.D. degree from New York University in 1972, did his surgery training at NYU-Bellevue Hospital in New York 1972-1974, and his Urology Residency at Stanford University 1974-1978. After 2 years on the faculty at Tulane University, he completed a fellowship in Urologic Oncology at UCLA in 1982. He was on the faculty of the Division of Urology at the University of Wisconsin from 1982-1995, being Director of their Urologic Oncology Program for the last 10 years.
He became the Winfield W Scott Professor and Chairman of the Department of Urology at the University of Rochester School of Medicine and Dentistry in August 1995, a position he held until 2018. He is now Professor of Urology and Oncology at the University of Rochester. He has also been the Director of the James P. Wilmot Cancer Center at the University of Rochester from 1996-1998. Dr. Messing has served as an Examiner on the American Board of Urology and American Urological Association (AUA) Joint Examining Committee, and served on the AUA Guidelines Panel for the Evaluation of Hematuria. Dr. Messing also has held a leadership position on the Renal Cancer Subcommittee of the GU Committee of the Southwest Oncology Group (SWOG) and was formerly co-chair of the GU Committee of the Eastern Cooperative Oncology Group (ECOG). He has been President of the Society of Urologic Oncology (SUO) and of the Northeastern Section of the AUA.
Dr. Messing is a renowned expert on the diagnosis, prevention, and treatment of cancers of the bladder, prostate, and kidney. He has conducted the first screening study for bladder cancer in a general population and carries on extensive research in the basic biology and epidemiology of these cancers. He has been the principal investigator on numerous clinical studies for the detection, prevention and treatment of them and is an active, practicing clinician.
These efforts have been recognized with Dr. Messing being awarded the prestigious AUA Presidential Citation in 2013 for “outstanding contributions in bladder cancer research and excellent service as an educator”, the SUO medal in 2016, the Ramon Guiteras Award (by its own description, the AUA’s highest honor for an academic urologist) for over 35 years of outstanding contributions to the art and science of urology, specifically urologic oncology in 2018, and the SUO’s Distinguished Service Award in 2020.